Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV

(2021) Nima Hemmat et al.   ARCHIVES OF VIROLOGY

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

(2020) Jiabao Xu et al.   Viruses-Basel

Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity

(2020) Yongkang Chen et al.   Frontiers in Microbiology

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

(2020) Hossam M. Ashour et al.   Pathogens

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

(2020) Maria Bzówka et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor

(2020) Se-Jin Park et al.   Science Advances

p38 MAPK inhibition: A promising therapeutic approach for COVID-19

(2020) Joseph M. Grimes et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Repositioning of 8565 Existing Drugs for COVID-19

(2020) Kaifu Gao et al.   Journal of Physical Chemistry Letters

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis

(2020) Rajaiah Alexpandi et al.   Frontiers in Microbiology

The SARS-CoV-2 main protease as drug target

(2020) Sven Ullrich et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Remdesivir: First Approval

(2020) Yvette N. Lamb   DRUGS

As a potential treatment of COVID-19: Montelukast

(2020) Cihan Fidan et al.   MEDICAL HYPOTHESES

Drug repurposing approach to fight COVID-19

(2020) Thakur Uttam Singh et al.   Pharmacological Reports

Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight

(2020) Mohd Imran Khan et al.   PLoS One

Repurposing antimalarials to tackle the COVID-19 pandemic

(2020) Sanjeev Krishna et al.   TRENDS IN PARASITOLOGY

Statin use is associated with lower disease severity in COVID-19 infection

(2020) Wilnard Y. T. Tan et al.   Scientific Reports

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

(2020) Omna Sharma et al.   Frontiers in Immunology

Oxford–AstraZeneca COVID-19 vaccine efficacy

(2020) Maria Deloria Knoll et al.   LANCET

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials

(2020) Jerome Amir Singh et al.   LANCET INFECTIOUS DISEASES

FDA Approval of Remdesivir — A Step in the Right Direction

(2020) Daniel Rubin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

(2020) Mohamed Mahdi et al.   Virology Journal

Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

(2020) Alina Shitrit et al.   Scientific Reports

Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer

(2019) Lunkun Ma et al.   Frontiers in Pharmacology

Repurposing an HIV Drug for Zika Virus Therapy

(2019) Xuping Xie et al.   MOLECULAR THERAPY

Drug repurposing for Ebola virus disease: principles of consideration and the Animal Rule

(2018) Jane P.F. Bai et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Proteases and protease inhibitors in infectious diseases

(2017) Ayodeji A. Agbowuro et al.   MEDICINAL RESEARCH REVIEWS

Drug repurposing in cancer

(2017) Linda Sleire et al.   PHARMACOLOGICAL RESEARCH

Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease

(2015) Peter Norman   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Database resources of the National Center for Biotechnology Information

(2015)   NUCLEIC ACIDS RESEARCH

GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit

(2013) Sander Pronk et al.   BIOINFORMATICS

Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β2-Agonist PF-00610355

(2013) Paul Matthias Diderichsen et al.   CLINICAL PHARMACOKINETICS

GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation

(2008) Berk Hess et al.   Journal of Chemical Theory and Computation

Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors

(2008) Veena Nukoolkarn et al.   JOURNAL OF THEORETICAL BIOLOGY